FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Panel to Discuss Cerexa for Intra-abdominal/UTIs

11/07/2014

Federal Register Notice: FDA’s Anti-Infective Drugs Advisory Committee will meet 12/5 from 8 a.m. to 4:30 p.m. at the Marrio...

FDA Sends Info on Antibacterial Drugs/Antimicrobial Testing to OMB

11/04/2014

Federal Register Notice: FDA’s proposed collection of information, “Guidance for Industry on Updating Labeling for Sus...

Info on Communications for CVM-Regulated Products Sent to OMB

11/04/2014

Federal Register Notice: FDA’s proposed collection of information “Testing Communications on FDA/Center for Veterinary...

Comments Sought on Dietary Supplement Guidance Info Collection

11/04/2014

Federal Register Notice: FDA is seeking comments on the information collection provisions of the FD&C Act and the document Guidanc...

Docket Set on Patient Participation in Product Discussions

11/04/2014

Federal Register Notice: FDA is establishing a public docket for comments on agency activities performed under the FDA Safety and ...

Comments Sought on Animal Extralabel Drug Use

11/04/2014

Federal Register Notice: FDA seeks comments on the reporting requirements associated with extralabel drug use in animals. Comments...

Comments Sought on Supplement GMP Info

12/19/2013

Federal Register Notice: FDA is seeking public comment on the information collection provisions of FDA’s current good manufa...

Comments Sought on Tobacco Substantial Equivalence Requirements

12/19/2013

OMB OKs Info on Device ID

12/19/2013

Federal Register Notice: FDA’s collection of information entitled “Unique Device Identification System,” has bee...

OMB OKs Info on Cardiovascular Labeling

12/19/2013

Federal Register Notice: FDA’s collection of information entitled “Guidance for Industry on Hypertension Indication: D...